Efficacy of Non-invasive NESA Neuromodulation in Fibromyalgia

Fibromyalgia is a chronic condition that causes pain throughout the body, fatigue and other symptoms. Among the most common clinical symptoms are sleep and anxiety disorders. All these symptoms are very disabling and have a negative impact on the quality of life of these people.There is currently no curative treatment for this pathology and current treatments focus their efforts on reducing the intensity of the symptoms. The current approach is mainly pharmacological, with the possible side effects that this entails.

Inclusion Criteria:Patients over 18 years of ageDiagnosis of Fibromyalgia meeting ACR 1990/20101,2 criteria, made by a physician, documented by a clinical report.Diagnosis of Fibromyalgia made at least 12 months agoStable baseline treatment in the month prior to inclusion in the studySigned informed consentIn normal condition and mentally competent to participate in the study.Able to complete the study questionnaires.Exclusion Criteria:Have any of the following contraindications for treatment with NESA XSIGNAL®: pacemakers, internal bleeding, not applying electrodes to skin in poor condition, with ulcerations or wounds, acute febrile processes, acute thrombophlebitis and/or phobia of electricity.Failure to sign the informed consent form.Active chronic inflammatory joint diseases.Active neurological diseases with central or peripheral nervous system involvement.Active systemic autoimmune diseasesPsychotic disordersActive concomitant neoplastic or infectious processesMedication changes in the month prior to study inclusion or throughout the duration of the study.